Times to pain relief and pain freedom with rizatriptan 10 mg and other oral triptans

International Journal of Clinical Practice

Volumn 61, Issue 7, 2007, Pages 1091-1111

  Ng Mak, D S ^a   Hu, X H ^a   Chen, Y ^a   Ma, L ^a   Solomon, G ^b  

^a MERCK RESEARCH LABORATORIES   (United States)

^b ADVOCATE LUTHERAN GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALMOTRIPTAN; ELETRIPTAN; FROVATRIPTAN; METHYLPREDNISOLONE; NARATRIPTAN; RIZATRIPTAN; SUMATRIPTAN; ZOLMITRIPTAN;

ADULT; ANALGESIA; ANALGESIC ACTIVITY; ARTICLE; CHRONOPHARMACOLOGY; CLINICAL TRIAL; CONFOUNDING VARIABLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG EFFECT; DRUG EFFICACY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIGRAINE; MULTICENTER STUDY; OPEN STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PRURITUS; URTICARIA;

ACUTE DISEASE; ADULT; CROSS-OVER STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; MIGRAINE DISORDERS; MULTIVARIATE ANALYSIS; PATIENT SATISFACTION; PROSPECTIVE STUDIES; SEROTONIN AGONISTS; TIME FACTORS; TREATMENT OUTCOME; TRIAZOLES; TRYPTAMINES;

EID: 34250677785     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1742-1241.2007.01400.x     Document Type: Article

References (19)

1. Lipton RB, Stewart WF, Diamond S, Diamond ML, Reed M. Prevalence and burden of migraine in the United States: data from the American Migraine Study II. Headache 2001 41: 646 57.
2. Elrington G. Migraine: diagnosis and management. J Neurol Neurosurg Psychiatry 2002 72 (Suppl. 2 ii10 5.
3. Narbone MC, Abbate M, Gangemi S. Acute drug treatment of migraine attack. Neurol Sci 2004 25 (Suppl. 3 S113 118.
4. Silberstein, SD. Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2000 55: 754 62.
5. Christie S, Gobel H, Mateos V, Allen C, Vrijens F, Shivaprakash M. Crossover comparison of efficacy and preference for rizatriptan 10 mg versus ergotamine/caffeine in migraine. Eur Neurol 2003 49: 20 9.
6. The Multinational Oral Sumatriptan and Cafergot Comparative Study Group. A randomized, double-blind comparison of sumatriptan and Cafergot in the acute treatment of migraine. Eur Neurol 1991 31: 314 22.
7. Diener HC, Jansen JP, Reches A, Pascual J, Pitei D, Steiner TJ. Efficacy, tolerability and safety of oral eletriptan and ergotamine plus caffeine (Cafergot) in the acute treatment of migraine: a multicentre, randomised, double-blind, placebo-controlled comparison. Eur Neurol 2002 47: 99 107.
8. Adelman JU, Lipton RB, Ferrari MD et al. Comparison of rizatriptan and other triptans on stringent measures of efficacy. Neurology 2001 57: 1377 83.
9. Tfelt-Hansen P, Teall J, Rodriguez F et al. Oral rizatriptan versus oral sumatriptan: a direct comparative study in the acute treatment of migraine. Headache 1998 38: 748 55.
10. Tfelt-Hansen P, Block G, Dahlof C et al. Guidelines for controlled trials of drugs in migraine: second edition. Cephalalgia 2000 20: 765 86.
11. Kolodny A, Polis A, Battisti WP, Johnson-Pratt L, Skobieranda F, on behalf of The Rizatriptan Protocol 052 Study Group Comparison of rizatriptan 5 mg and 10 mg tablets and sumatriptan 25 mg and 50 mg tablets. Cephalalgia 2004 24: 540 6.
12. Adelman JU, Belsey J. Meta-analysis of oral triptan therapy for migraine: number needed to treat and relative cost to achieve relief within 2 hours. J Manag Care Pharm 2003 9: 45 52.
13. Ferrari MD, Roon KI, Lipton RB, Goadsby PJ. Oral triptans (serotonin 5-HT(1B/1D) agonists) in acute migraine treatment: a meta-analysis of 53 trials. Lancet 2001 358: 1668 75.
14. Solomon S, Frishberg B, Hu XH, Markson L, Berger M. Migraine treatment outcomes with rizatriptan in triptan-naive patients: a naturalistic study. Clin Ther 2001 23: 886 900.
15. Baos V, Serrano A, Torrecilla M et al. Patient-reported benefits of rizatriptan compared with usual non-triptan therapy for migraine in a primary care setting. Int J Clin Pract 2003 57: 761 8.
16. Cady R, Martin V, Adelman J, Diamond M, Sajjan S, Hu XH. Migraine treatment with rizatriptan and non-triptan usual care medications: a pharmacy-based study. Headache 2004 44: 900 7.
17. Bell CF, Foley KA, Barlas S, Solomon G, Hu XH. Time to pain freedom and onset of pain relief with rizatriptan 10 mg and prescription usual-care oral medications in the acute treatment of migraine headaches: a multicenter, prospective, open-label, two-attack, crossover study. Clin Ther 2006 28: 872 80.
18. Diez FI, Straube A, Zanchin G. Patient preference in migraine therapy. A randomized, open-label, crossover clinical trial of acute treatment of migraine with oral almotriptan and rizatriptan. J Neurol 2007 254: 242 9.
19. Jamieson D, Cutrer FM, Goldstein J, Dayno J, Hu XH. Real-world experiences in migraine therapy with rizatriptan. Headache 2003 43: 223 30.